La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
China Medical System Holdings Performance dei guadagni passati
Il passato criteri di controllo 2/6
China Medical System Holdings ha registrato una crescita degli utili a un tasso medio annuo di 4%, mentre il settore Pharmaceuticals ha registrato utili in crescita a un tasso medio annuo di 5.8%. I ricavi sono stati in crescita a un tasso medio annuo di 7.4%. Il ritorno sul capitale proprio di China Medical System Holdings è 8.6% e ha margini netti di 19.8%.
Informazioni chiave
4.0%
Tasso di crescita degli utili
4.3%
Tasso di crescita dell'EPS
| Pharmaceuticals Crescita del settore | 5.6% |
| Tasso di crescita dei ricavi | 7.4% |
| Rendimento del capitale proprio | 8.6% |
| Margine netto | 19.8% |
| Ultimo aggiornamento sui guadagni | 30 Jun 2024 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings
Jul 15
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued
May 22China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
May 03We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package
May 02China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 19China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
Mar 29Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%
Mar 28China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up
Dec 21Is China Medical System Holdings (HKG:867) A Risky Investment?
Dec 04If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Nov 15China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342
Aug 31China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Aug 30Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today
Aug 07We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease
May 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 26An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued
Feb 05China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly
Dec 26If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Dec 08Is China Medical System Holdings (HKG:867) Using Too Much Debt?
Sep 14China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year
Aug 25Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?
Aug 15An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued
Jul 08Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
May 16Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Apr 10China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28
Mar 22If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late
Feb 09Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Dec 25Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
Nov 10China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Sep 25China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32
Aug 26Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching
Jul 30An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued
Jun 27China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Jun 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 20Ripartizione dei ricavi e delle spese
Come China Medical System Holdings guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
| Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 30 Jun 24 | 7,014 | 1,390 | 3,272 | 225 |
| 31 Mar 24 | 7,514 | 1,896 | 3,220 | 210 |
| 31 Dec 23 | 8,013 | 2,401 | 3,168 | 195 |
| 30 Sep 23 | 8,663 | 2,891 | 3,313 | 170 |
| 30 Jun 23 | 9,313 | 3,381 | 3,457 | 146 |
| 31 Mar 23 | 9,232 | 3,320 | 3,408 | 136 |
| 31 Dec 22 | 9,150 | 3,259 | 3,358 | 125 |
| 30 Sep 22 | 9,046 | 3,224 | 3,347 | 129 |
| 30 Jun 22 | 8,942 | 3,189 | 3,336 | 133 |
| 31 Mar 22 | 8,640 | 3,103 | 3,159 | 124 |
| 31 Dec 21 | 8,337 | 3,017 | 2,981 | 115 |
| 30 Sep 21 | 8,009 | 2,948 | 2,782 | 94 |
| 30 Jun 21 | 7,681 | 2,878 | 2,583 | 73 |
| 31 Mar 21 | 7,313 | 2,704 | 2,444 | 70 |
| 31 Dec 20 | 6,946 | 2,530 | 2,304 | 67 |
| 30 Sep 20 | 6,582 | 2,300 | 2,198 | 63 |
| 30 Jun 20 | 6,217 | 2,070 | 2,092 | 60 |
| 31 Mar 20 | 6,145 | 2,015 | 2,119 | 53 |
| 31 Dec 19 | 6,074 | 1,961 | 2,145 | 45 |
| 30 Sep 19 | 5,908 | 2,011 | 2,103 | 30 |
| 30 Jun 19 | 5,743 | 2,062 | 2,060 | 15 |
| 31 Mar 19 | 5,588 | 1,956 | 1,988 | 8 |
| 31 Dec 18 | 5,433 | 1,850 | 1,916 | 0 |
| 30 Sep 18 | 5,375 | 1,839 | 1,829 | 0 |
| 30 Jun 18 | 5,317 | 1,827 | 1,743 | 0 |
| 31 Mar 18 | 5,333 | 1,751 | 1,674 | 0 |
| 31 Dec 17 | 5,349 | 1,675 | 1,604 | 0 |
| 30 Sep 17 | 5,379 | 1,601 | 1,566 | 0 |
| 30 Jun 17 | 5,410 | 1,527 | 1,529 | 0 |
| 31 Mar 17 | 5,155 | 1,452 | 1,462 | 0 |
| 31 Dec 16 | 4,901 | 1,376 | 1,395 | 0 |
| 30 Sep 16 | 4,477 | 1,265 | 1,259 | 0 |
| 30 Jun 16 | 4,054 | 1,155 | 1,123 | 0 |
| 31 Mar 16 | 3,804 | 1,075 | 1,065 | 0 |
| 31 Dec 15 | 3,553 | 996 | 1,007 | 0 |
| 30 Sep 15 | 3,404 | 1,062 | 957 | 0 |
| 30 Jun 15 | 3,255 | 1,128 | 908 | 0 |
| 31 Mar 15 | 3,100 | 1,087 | 845 | 0 |
| 31 Dec 14 | 2,945 | 1,046 | 783 | 0 |
| 30 Sep 14 | 2,760 | 890 | 729 | 0 |
| 30 Jun 14 | 2,575 | 734 | 676 | 0 |
| 31 Mar 14 | 2,412 | 685 | 644 | 0 |
| 31 Dec 13 | 2,249 | 636 | 613 | 0 |
Guadagni di qualità: 867 ha guadagni di alta qualità.
Margine di profitto in crescita: Gli attuali margini di profitto netti di 867 (19.8%) sono inferiori rispetto allo scorso anno (36.3%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: Gli utili di 867 sono cresciuti del 4% all'anno negli ultimi 5 anni.
Accelerare la crescita: 867 ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.
Guadagni vs Settore: 867 ha avuto una crescita negativa degli utili ( -58.9% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Pharmaceuticals ( 3.8% ).
Rendimento del capitale proprio
ROE elevato: Il Return on Equity ( 8.6% ) di 867 è considerato basso.